Tristel plc (LON:TSTL - Get Free Report) shares crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 438.78 ($5.65) and traded as low as GBX 425.70 ($5.48). Tristel shares last traded at GBX 435 ($5.60), with a volume of 26,712 shares traded.
Tristel Stock Up 2.7 %
The firm has a market capitalization of £212.82 million, a PE ratio of 3,488.46 and a beta of 0.23. The company has a quick ratio of 3.83, a current ratio of 4.92 and a debt-to-equity ratio of 19.12. The business's 50-day moving average price is GBX 403.70 and its 200-day moving average price is GBX 438.78.
Tristel Increases Dividend
The firm also recently declared a dividend, which will be paid on Friday, December 20th. Shareholders of record on Thursday, November 28th will be paid a dividend of GBX 8.28 ($0.11) per share. The ex-dividend date is Thursday, November 28th. This represents a yield of 2.1%. This is an increase from Tristel's previous dividend of $5.24. Tristel's payout ratio is currently 10,000.00%.
Insiders Place Their Bets
In other news, insider Elizabeth Dixon sold 50,000 shares of Tristel stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of GBX 397 ($5.11), for a total value of £198,500 ($255,436.88). Insiders own 4.89% of the company's stock.
About Tristel
(
Get Free Report)
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
Featured Articles
Before you consider Tristel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tristel wasn't on the list.
While Tristel currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
